Skip to main content

Joaquin Burgos Cibrian

Institutions of which they are part

Main researcher
Infectious Diseases
Vall Hebron Institut de Recerca

Joaquin Burgos Cibrian

Institutions of which they are part

Main researcher
Infectious Diseases
Vall Hebron Institut de Recerca

Projects

Incorporació Dr. Esteve Ribera a la RETICS en SIDA

IP: -
Collaborators: Adria Curran Fàbregas, Vicenç Falcó Ferrer, Inmaculada Ocaña Rivera, Estrella Caballero Requero, Ariadna Rando Segura, Pere Soler Palacín, María José Buzón Gómez, Paula Suanzes Diez, Jordi Navarro Mercadé, Joaquin Burgos Cibrian, Joan Rey Cano, Meritxell Genesca Ferrer, Marie Antoinette Frick, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas
Funding agency: Instituto de Salud Carlos III
Funding: 247500
Reference: RD16/0025/0007
Duration: 01/01/2017 - 30/06/2022

Incorporació del candidat a l'àrea de Malalties Infeccioses

IP: -
Collaborators: Joaquin Burgos Cibrian, Laia Perez Lasarte
Funding agency: Instituto de Salud Carlos III
Funding: 135000
Reference: JR15/00015
Duration: 01/01/2016 - 31/12/2018

Malalties Infeccioses (GRC)

IP: -
Collaborators: Adria Curran Fàbregas, Oscar Len Abad, Manuel Crespo Casal, Inmaculada Ocaña Rivera, Nuria Fernández Hidalgo, Joan Gavaldà Santapau, Esteve Ribera Pascuet, Ma Dolores Rodríguez Pardo, Israel Molina Romero, Fernando M Salvador Velez, Carles Pigrau Serrallach, Isabel Ruiz Camps, Jordi Navarro Mercadé, Joaquin Burgos Cibrian, Adrián Sánchez Montalvá
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 759
Duration: 01/01/2014 - 31/12/2016

Malalties infeccioses

IP: Albert Pahissa Berga
Collaborators: Joaquin Burgos Cibrian, Laia Perez Lasarte
Funding agency: Instituto de Salud Carlos III
Funding: 72000
Reference: CM12/00207
Duration: 01/01/2013 - 31/12/2014

Related news

AIDAY 2026 showcased the artificial intelligence initiatives, infrastructures and projects already being developed across the Campus.

All patients showed a favorable clinical course and responded well to antibiotic treatment, without complications.

The study results show that the local presence of IL-1β promotes the development of myeloid cells with an immunosuppressive function.

Related professionals

Manuel Requena Ruiz

Manuel Requena Ruiz

Postdoctoral researcher
Stroke research
Read more
Meritxell Ventura Cots

Meritxell Ventura Cots

Main researcher
Liver Diseases
Read more
Lara Aguilera  Castro

Lara Aguilera Castro

Main researcher
Physiology and Pathophysiology of the Digestive Tract
Read more
Javier Garcia Fernandez

Javier Garcia Fernandez

Main researcher
Multidisciplinary Nursing Research Group
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.